Jennifer Hill
Family · Colorado Springs, CONPI 1528729175
Payments from drug & device makers
Across 92 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$514
- GSK$149
- Novo Nordisk$138
- Sanofi-aventis U.S. LLC$136
- Idorsia Pharmaceuticals US Inc$121
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$111
- plus $693 from 16 others
What the payments were for
- Food & beverage$1,862100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $514 |
| GSK | 4 | $149 |
| Novo Nordisk | 7 | $138 |
| Sanofi-aventis U.S. LLC | 7 | $136 |
| Idorsia Pharmaceuticals US Inc | 1 | $121 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $111 |
| Livanova USA, Inc. | 1 | $110 |
| AstraZeneca | 4 | $84 |
| Amarin Pharma, Inc. | 4 | $70 |
| Lilly USA, LLC | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Neurocrine Biosciences, Inc. | 2 | $60 |
| Amgen | 3 | $54 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $31 |
| Radius Health, Inc. | 1 | $24 |
| Pfizer | 1 | $22 |
| Atricure, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| Scpharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $15 |
| Acerus Pharmaceuticals Corporation | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,862 in reported general payments places this provider in the 85th percentile of 2,182 family providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 12 | $61,257 |
| MounjaroTirzepatide | 26 | $41,573 |
| Rosuvastatin Calcium | 34 | $361 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $230 |
| Amlodipine Besylate | 15 | $57 |
| Lisinopril | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $67 | $41,57326 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,182 family providers in Colorado.
Other family in Colorado Springs
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- Jeannette LillerColorado Springs$74K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Barbara ChamnessColorado Springs$15K
- Julie UnruhColorado Springs$14K
- Lisa HutchcraftColorado Springs$13K
- Kristin SekelskyColorado Springs$10K
- Leandrea TzitzicasColorado Springs$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.